Krishna Institute of Medical Sciences Limited (NSE:KIMS)

NSE:KIMS Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	34,017	30,351	24,982	21,977	16,508	13,299
Revenue	34,017	30,351	24,982	21,977	16,508	13,299
Revenue Growth (YoY)	25.74%	21.49%	13.68%	33.13%	24.13%	18.46%
Cost of Revenue	13,816	12,128	10,160	8,793	6,676	5,535
Gross Profit	20,201	18,223	14,822	13,184	9,832	7,764
Selling, General & Admin	477	477	495	352.46	205.01	178.24
Other Operating Expenses	11,897	9,910	7,950	6,784	4,429	3,851
Operating Expenses	14,541	12,159	9,910	8,429	5,361	4,733
Operating Income	5,660	6,064	4,912	4,755	4,471	3,031
Interest Expense	-1,285	-887	-464	-293.18	-159.21	-293.02
Interest & Investment Income	102	102	23	95.32	122.82	57.99
Earnings From Equity Investments	-	-	-3	-	95.1	-
Other Non Operating Income (Expenses)	151	134	70	29.43	23.15	-2.9
EBT Excluding Unusual Items	4,628	5,413	4,538	4,586	4,553	2,793
Gain (Loss) on Sale of Investments	48	48	41	30.01	-	-
Gain (Loss) on Sale of Assets	109	109	4	6.1	-27.17	-10.79
Other Unusual Items	8	11	12	226.72	42.41	7.52
Pretax Income	4,793	5,581	4,595	4,849	4,569	2,790
Income Tax Expense	1,234	1,433	1,236	1,191	1,131	735.36
Earnings From Continuing Operations	3,559	4,148	3,359	3,658	3,438	2,055
Minority Interest in Earnings	-199	-303	-259	-294.91	-111.1	-42.6
Net Income	3,360	3,845	3,100	3,363	3,327	2,012
Net Income to Common	3,360	3,845	3,100	3,363	3,327	2,012
Net Income Growth	1.40%	24.03%	-7.83%	1.09%	65.33%	68.83%
Shares Outstanding (Basic)	400	400	400	400	397	374
Shares Outstanding (Diluted)	400	400	400	400	397	381
Shares Change (YoY)	-0.03%	-	-	0.74%	4.32%	1.42%
EPS (Basic)	8.40	9.61	7.75	8.41	8.38	5.37
EPS (Diluted)	8.40	9.61	7.75	8.41	8.38	5.28
EPS Growth	1.45%	24.03%	-7.83%	0.35%	58.51%	66.48%
Free Cash Flow	-7,669	-4,271	-1,261	-1,424	1,537	2,615
Free Cash Flow Per Share	-19.17	-10.67	-3.15	-3.56	3.87	6.87
Gross Margin	59.38%	60.04%	59.33%	59.99%	59.56%	58.38%
Operating Margin	16.64%	19.98%	19.66%	21.63%	27.09%	22.79%
Profit Margin	9.88%	12.67%	12.41%	15.30%	20.15%	15.13%
Free Cash Flow Margin	-22.55%	-14.07%	-5.05%	-6.48%	9.31%	19.67%
EBITDA	7,535	7,544	6,199	5,828	5,120	3,661
EBITDA Margin	22.15%	24.86%	24.81%	26.52%	31.01%	27.52%
D&A For EBITDA	1,875	1,480	1,287	1,073	648.09	629.24
EBIT	5,660	6,064	4,912	4,755	4,471	3,031
EBIT Margin	16.64%	19.98%	19.66%	21.63%	27.09%	22.79%
Effective Tax Rate	25.75%	25.68%	26.90%	24.56%	24.75%	26.36%
Revenue as Reported	34,353	30,670	25,143	22,236	16,711	13,401
Advertising Expenses	-	329	252	197.39	111.51	91.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.